146 related articles for article (PubMed ID: 36288465)
1. Potent Uncompetitive Inhibitors of Nicotinamide
Barrows RD; Jeffries DE; Vishe M; Tukachinsky H; Zheng SL; Li F; Ma Z; Li X; Jin S; Song H; Zhang R; Zhang S; Ni J; Luan H; Wen L; Rongshan Y; Ying C; Shair MD
J Med Chem; 2022 Nov; 65(21):14642-14654. PubMed ID: 36288465
[TBL] [Abstract][Full Text] [Related]
2. Kinetic Mechanism of Nicotinamide N-Methyltransferase.
Loring HS; Thompson PR
Biochemistry; 2018 Sep; 57(38):5524-5532. PubMed ID: 30148963
[TBL] [Abstract][Full Text] [Related]
3. Potent Inhibition of Nicotinamide
Gao Y; van Haren MJ; Buijs N; Innocenti P; Zhang Y; Sartini D; Campagna R; Emanuelli M; Parsons RB; Jespers W; Gutiérrez-de-Terán H; van Westen GJP; Martin NI
J Med Chem; 2021 Sep; 64(17):12938-12963. PubMed ID: 34424711
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of nicotinamide N-methyltransferase designed to mimic the methylation reaction transition state.
van Haren MJ; Taig R; Kuppens J; Sastre Toraño J; Moret EE; Parsons RB; Sartini D; Emanuelli M; Martin NI
Org Biomol Chem; 2017 Aug; 15(31):6656-6667. PubMed ID: 28758655
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT).
Babault N; Allali-Hassani A; Li F; Fan J; Yue A; Ju K; Liu F; Vedadi M; Liu J; Jin J
J Med Chem; 2018 Feb; 61(4):1541-1551. PubMed ID: 29320176
[TBL] [Abstract][Full Text] [Related]
6. Bisubstrate Inhibitors of Nicotinamide
Gao Y; van Haren MJ; Moret EE; Rood JJM; Sartini D; Salvucci A; Emanuelli M; Craveur P; Babault N; Jin J; Martin NI
J Med Chem; 2019 Jul; 62(14):6597-6614. PubMed ID: 31265285
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma elevates nicotinamide N-methyltransferase activity and nicotinamide level in human glioma cells.
Yamada K; Miyazaki T; Hara N; Tsuchiya M
J Nutr Sci Vitaminol (Tokyo); 2010; 56(2):83-6. PubMed ID: 20495288
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation.
Roberti A; Fernández AF; Fraga MF
Mol Metab; 2021 Mar; 45():101165. PubMed ID: 33453420
[TBL] [Abstract][Full Text] [Related]
9. Covalent inhibitors of nicotinamide N-methyltransferase (NNMT) provide evidence for target engagement challenges in situ.
Lee HY; Suciu RM; Horning BD; Vinogradova EV; Ulanovskaya OA; Cravatt BF
Bioorg Med Chem Lett; 2018 Sep; 28(16):2682-2687. PubMed ID: 29731364
[TBL] [Abstract][Full Text] [Related]
10. The kinetic analysis of the N-methylation of 4-phenylpyridine by nicotinamide N-methyltransferase: Evidence for a novel mechanism of substrate inhibition.
van Haren MJ; Thomas MG; Sartini D; Barlow DJ; Ramsden DB; Emanuelli M; Klamt F; Martin NI; Parsons RB
Int J Biochem Cell Biol; 2018 May; 98():127-136. PubMed ID: 29549048
[TBL] [Abstract][Full Text] [Related]
11. Complex roles of nicotinamide N-methyltransferase in cancer progression.
Wang W; Yang C; Wang T; Deng H
Cell Death Dis; 2022 Mar; 13(3):267. PubMed ID: 35338115
[TBL] [Abstract][Full Text] [Related]
12. Enhancing nicotinamide N-methyltransferase bisubstrate inhibitor activity through 7-deazaadenosine and linker modifications.
Li P; Xia C; Kong X; Zhang J
Bioorg Chem; 2024 Feb; 143():106963. PubMed ID: 38048700
[TBL] [Abstract][Full Text] [Related]
13. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice.
Neelakantan H; Vance V; Wetzel MD; Wang HL; McHardy SF; Finnerty CC; Hommel JD; Watowich SJ
Biochem Pharmacol; 2018 Jan; 147():141-152. PubMed ID: 29155147
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of monkey and mouse nicotinamide N-methyltransferase (NNMT) bound with end product, 1-methyl nicotinamide.
Swaminathan S; Birudukota S; Thakur MK; Parveen R; Kandan S; Juluri S; Shaik S; Anand NN; Burri RR; Kristam R; Hallur MS; Rajagopal S; Schreuder H; Langer T; Rudolph C; Ruf S; Dhakshinamoorthy S; Gosu R; Kannt A
Biochem Biophys Res Commun; 2017 Sep; 491(2):416-422. PubMed ID: 28720493
[TBL] [Abstract][Full Text] [Related]
15. Exploring Unconventional SAM Analogues To Build Cell-Potent Bisubstrate Inhibitors for Nicotinamide N-Methyltransferase.
Iyamu ID; Vilseck JZ; Yadav R; Noinaj N; Huang R
Angew Chem Int Ed Engl; 2022 Apr; 61(16):e202114813. PubMed ID: 35134268
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide-N-methyltransferase regulates lipid metabolism via SAM and 1-methylnicotinamide in the AML12 hepatocyte cell line.
Yoda M; Mizuno R; Izumi Y; Takahashi M; Bamba T; Kawaoka S
J Biochem; 2023 Jun; 174(1):89-98. PubMed ID: 37014628
[TBL] [Abstract][Full Text] [Related]
17. Binding Affinity Studies of Nicotinamide N-methyltransferase and Ligands by Saturation Transfer Difference NMR.
Fang T; Zhang J
Protein Pept Lett; 2023; 30(9):734-742. PubMed ID: 37622714
[TBL] [Abstract][Full Text] [Related]
18. Novel Inhibitors of Nicotinamide-
Kannt A; Rajagopal S; Hallur MS; Swamy I; Kristam R; Dhakshinamoorthy S; Czech J; Zech G; Schreuder H; Ruf S
Molecules; 2021 Feb; 26(4):. PubMed ID: 33668468
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide N-methyltransferase ameliorates renal fibrosis by its metabolite 1-methylnicotinamide inhibiting the TGF-β1/Smad3 pathway.
Zhang W; Rong G; Gu J; Fan C; Guo T; Jiang T; Deng W; Xie J; Su Z; Yu Q; Mai J; Zheng R; Chen X; Tang X; Zhang J
FASEB J; 2022 Mar; 36(3):e22084. PubMed ID: 35107844
[TBL] [Abstract][Full Text] [Related]
20. Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts.
Eckert MA; Coscia F; Chryplewicz A; Chang JW; Hernandez KM; Pan S; Tienda SM; Nahotko DA; Li G; Blaženović I; Lastra RR; Curtis M; Yamada SD; Perets R; McGregor SM; Andrade J; Fiehn O; Moellering RE; Mann M; Lengyel E
Nature; 2019 May; 569(7758):723-728. PubMed ID: 31043742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
